Personalizing Advanced Prostate Cancer Treatment--At the 2015 medical conference ASCO GU, leading prostate cancer researchers gathered to share progress in treating and understanding the disease. Dr. Emmanuel Antonarakis, from the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, presented his work in advanced prostate cancer and the use of a blood-based biomarker to help select patients for chemotherapy.
#Therapy #NHS NHS fast-tracks drug docetaxel for advanced prostate cancer patients Angela Culhane, the chief executive of Prostate Cancer UK, said the announcement was great news for men newly diagnosed with advanced prostate cancer. http://www.theguardian.com/society/2016/jan/24/nhs-fast-tracks-drug-docetaxel-advanced-prostate-cancer
Prostate Cancer - PSA, HPC, Colon - Life Extension Health Concern